Iron deficiency is associated with larger infarctions and increased risk of adverse ventricular remodelling, according to a new study of Vall d'Hebron

The study shows that not only excess but also iron deficiency can have detrimental effects in acute myocardial ischemia.

21/09/2021

A new study by the Cardiovascular Diseases group at Vall d'Hebron Research Institute (VHIR) and CIBER of Cardiovascular Diseases (CIBERCV) has shown that patients with acute myocardial infarction who are iron deficient have larger infarctions and develop with a higher frequency adverse heart remodelling than patients with normal iron levels. The study is published in the journal JACC: Basic to Translational Science.

Iron is essential for normal cardiovascular function. In patients with chronic heart failure, iron deficiency is common independently of anaemia and portends a poorer prognosis. Its correction improves symptoms and quality of life. While excess iron has been associated with cellular damage, the significance of iron deficiency in acute coronary syndromes has been little studied.

The study correlated iron deficiency with larger infarct size, more extensive microvascular obstruction and an increased risk of developing adverse ventricular remodelling, after analysing MRI scans of 125 patients who had suffered an acute ST-segment elevation myocardial infarction (STEMI) and following them up at 6 months.

The study was led by Dr. Javier Inserte and Dr. José A. Barrabés, researchers from the Cardiovascular Diseases research group at VHIR and the Cardiology Department at Vall d'Hebron University Hospital, in collaboration with the Departments of Haematology and Biochemistry at the same hospital, as well as the CIBERCV.

According to Dr. Inserte, "our study demonstrates that not only iron excess but also iron deficiency can have detrimental effects in the context of acute myocardial ischaemia. The findings thus justify caution about the use of iron-depleting therapies in these patients".

In addition to the human study, the work includes experimental studies in mice fed an iron-deficient diet and subjected to a protocol that mimics infarction in humans. These studies confirm the results obtained in patients and served to propose increased oxidative stress and altered nitric oxide production as mechanisms responsible for the detrimental effects of iron deficiency.

"These results justify further research, especially to assess whether the correction of iron deficiency can have beneficial effects on ventricular dilatation and the development of heart failure in patients who have suffered an extensive infarction", explains Dr. Barrabés.

Share it:

Related news

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.